PTEN and neoplasm: ZMEL1, generated from BRAFV600E/p53−/− melanomas, is widely used for metastasis modeling, drug resistance studies, and CRISPR-mediated genome editing [30], while PTEN-deficient tumor-derived cells enable investigation of tumor angiogenesis and resistance mechanisms in a zebrafish-specific context [21].